Why Tirzepatide Causes Burping
US$ 21.99
invest in semaglutide Obesity Drug Stocks: Where to Now Novo Nordisk Shares Down 43%
Description
GLP-1 medications have transformed weight loss treatment, but cost remains a barrier for many patients
GLP-1 medications like semaglutide (Ozempic and Wegovy) are often around weight loss, but the science on long-term health changed my mind.
Recent estimates suggest that around 1.6 million adults used GLP-1 weight-loss drugs between early 2024 and early 2025, while broader data indicates up to 1.5 million people are currently taking them at any one time1
And how do they compare to weight loss injections like Mounjaro and Wegovy
